Investigator-Initiated Trials : Key Concepts and Best Practice
- UE code MSBMM213
-
Schedule
12Quarter 1
- ECTS Credits 2
-
Language
Français
Clinical Trials [MSBMM103]
By the end of the course the student will:
This module will focus on providing an understanding of the challenge and interest of developing investigator-initiated trials in Belgium and worldwide.
Students will learn about the practical steps involved in setting up and managing investigator-initiated clinical trials.
Investigator-initiated trials are clinical trials initiated and managed by a non-pharmaceutical company researchers, like individual investigators, institutions, collaborative study groups or cooperative groups.
The researcher is responsible for the legal and regulatory responsibilities of the trial sponsor for the conduct and management of the study as defined by all applicable laws and regulations.
Although initiating investigator-initiated trial provides greater flexibility, it comes with greater responsibilities, must fulfil the same regulatory and legal requirements and must achieve the same quality than industry initiated trials.
Based on experience this module will walk you through the lifecycle of an investigator-initiated trial from design to publication and the key steps involved in their delivery.
Students will receive practical exercises related to investigator-initiated trial to prepare and to present.
Oral evaluation
IHC guidelines, EU directives, Belgium laws
Training | Study programme | Block | Credits | Mandatory |
---|---|---|---|---|
Master 120 en sciences biomédicales à finalité spécialisée en recherche préclinique | Standard | 0 | 2 | |
Master 120 en sciences biomédicales à finalité spécialisée en recherche clinique | Standard | 0 | 2 | |
Master 120 en sciences biomédicales à finalité spécialisée en recherche préclinique | Standard | 2 | 2 | |
Master 120 en sciences biomédicales à finalité spécialisée en recherche clinique | Standard | 2 | 2 |